Abstract:Objective To analyze the clinical significance of high-sensitivity C-reactive protein(hs-CRP) in blood-activating and toxin-resolving medicine for unstable angina(USA) patients,and a preliminary exploration of its secondary index.Methods Sixty-five USA patients hospitalized in department of cardiology,Anzhen Hospital Affiliated to Capital Medical University from March to September 2008 were randomly assigned into groups A(blood-activating group),B(blood-activating and toxin-resolving group).Excluding the patient does not meet the standards,and ultimately group were31 cases,30 cases of group B.Based on standard treatment of Western Medicine,group A were given Xiongshao capsules,group B given capsules of Xiongshao and Huanglian.The treatment lasted 1 month.Serum hs-CRP level,scores of angina,stagnation of blood and TCM main symptoms,changes of lipid parameters were compared between 2 groups before treatments and after.Results The level of serum hs-CRP was lower in group B than in group A before and after treatment(P0.05).There was no significant difference in hs-CRP between pre-and post-treatments in group A(P0.05).The level of hs-CRP was lower after treatment than before in group B(P0.05).There was no difference in score of angina between 2 groups before treatment(P0.05),and was lower in group B than in group A after treatment(P0.05),and was lower after treatment than before between 2 groups(P0.05).There was no difference in scores of stagnation of blood and TCM main symptoms between 2 groups(P0.05),and lower after treatment than before treatment between 2 groups(P0.05).There was no difference in TC,TG,LDL-C,HDL-C between 2 groups before and after treatment(P0.05),TC,LDL-C lower after treatment than before between 2 groups(P0.05).Conclusion Compared with group A,serum hs-CRP level was more significant in evaluating the clinical effects of blood-activating and toxin-resolving medicine on USA.Score of angina may be used as an auxiliary index assessing the clinical curative effects of medicines for USA.

The Inflammatory Factors Change in Patients with Acute Coronary Syndrome after Clinical Rosuvas-tatin Calcium Therapy

Effects of Different Doses of Rosuvastatin on High-sensitivity C-reactive Protein(hs-CRP) and Interleukin-6 (IL-6) in Patients with Acute Coronary Syndrome.

The Study of the Relation Between C-reactive Protein,fibrinogen and Acute Coronary Syndrome

Relationship Between Serum Concentrations of IL-18, IL-10, IL-6 and Acute Coronary Syndrome

Effects of Rosiglitazone on Serum Levels of Lipids and Inflammatory Factors in Atherosclerotic Rats

Study on the Relationship between Serum Resistin and Acute Coronary Syndrome and Stable Angina Pectoris

Inflammatory Factors in the Serum of Patients with Acute Coronary Syndrome:Changes and Their Implications

Effects of Rosuvastatin on Inflammatory Factors and Adiponectin in Patients with Acute Myocardial Infarction

Changes of Us-CRP and Lipids Levels of Acute Coronary Syndrome (ACS) by Intensive Atorvastatin Therapy

Clinic study on anti-inflammatory effects of atorvastatin associated with rampril in patients with acute coronary syndrome

The Effect of Simvastatin and Pravastatin on Serum Lipid and C Reactive Protein in Patients with Acute Coronary Syndrome

The Efficacy and Safety of Short Term Intensive Rosuvastatin Therapy in Acute Coronary Syndrome

Influence of Short-Term Treatment with Simvastatin 40 Mg on Plasma Concentration of High-Sensitivity C-reactive Protein in Patients with Unstable Angina Pectoris

Clinical study on the effect and security of different doses of rosuvastatin therapy in acute coronary syndrome ;patients with diabetes

Study of curative effect of acute coronary syndrome by intensive atorvastatin therapy

[Non-ST-elevation acute coronary syndrome. Comparison of effects of atorvastatin and rosuvastatin on blood levels of lipids and markers of inflammation]

Effects of Atorvastatin on Interleukin-1 and C-reactive Protein Levels of Patients with Acute Myocardial Infarction

Effect of Early Treatment with Atorvastatin on Serum Levels of Inflammatory Cytokines in Patients with Unstable Angina Pectoris

Effect of atorvastatin on the expression of fractalkine in the circulation of patients with acute coronary syndrome

Clinical Significance of High-sensitivity C-reactive Protein in Blood-activating and Toxin-resolving Medicine for Unstable Angina Patients

Study in the relationship between severity of coronary artery disease and high sensitive-C reaction protein as well as insulin resistance